Literature DB >> 26865085

The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders?

Javier Ochoa-Repáraz1, Lloyd H Kasper2.   

Abstract

The gut-brain axis is a bi-directional integrated system composed by immune, endocrine, and neuronal components by which the gap between the gut microbiota and the brain is significantly impacted. An increasing number of different gut microbial species are now postulated to regulate brain function in health and disease. The westernized diet is hypothesized to be the cause of the current obesity levels in many countries, a major socio-economical health problem. Experimental and epidemiological evidence suggest that the gut microbiota is responsible for significant immunologic, neuronal, and endocrine changes that lead to obesity. We hypothesize that the gut microbiota, and changes associated with diet, affect the gut-brain axis and may possibly contribute to the development of mental illness. In this review, we discuss the links between diet, gut dysbiosis, obesity, and immunologic and neurologic diseases that impact brain function and behavior.

Entities:  

Keywords:  CNS diseases; Diet; Dysbiosis; Gut microbiota; Gut-brain axis; Obesity

Mesh:

Year:  2016        PMID: 26865085      PMCID: PMC4798912          DOI: 10.1007/s13679-016-0191-1

Source DB:  PubMed          Journal:  Curr Obes Rep        ISSN: 2162-4968


  114 in total

1.  Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats.

Authors:  Michèle Crumeyrolle-Arias; Mathilde Jaglin; Aurélia Bruneau; Sylvie Vancassel; Ana Cardona; Valérie Daugé; Laurent Naudon; Sylvie Rabot
Journal:  Psychoneuroendocrinology       Date:  2014-01-31       Impact factor: 4.905

2.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

3.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.

Authors:  Ivan Monteleone; Angelamaria Rizzo; Massimiliano Sarra; Giuseppe Sica; Pierpaolo Sileri; Livia Biancone; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

4.  Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells.

Authors:  Rafael M Rezende; Rafael P Oliveira; Samara R Medeiros; Ana C Gomes-Santos; Andrea C Alves; Flávia G Loli; Mauro A F Guimarães; Sylvia S Amaral; André P da Cunha; Howard L Weiner; Vasco Azevedo; Anderson Miyoshi; Ana M C Faria
Journal:  J Autoimmun       Date:  2012-08-28       Impact factor: 7.094

5.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

6.  Gut microbiota in multiple sclerosis: possible influence of immunomodulators.

Authors:  Brandi L Cantarel; Emmanuelle Waubant; Christel Chehoud; Justin Kuczynski; Todd Z DeSantis; Janet Warrington; Arun Venkatesan; Claire M Fraser; Ellen M Mowry
Journal:  J Investig Med       Date:  2015-06       Impact factor: 2.895

Review 7.  Immunogenetic control of the intestinal microbiota.

Authors:  Eric Marietta; Abdul Rishi; Veena Taneja
Journal:  Immunology       Date:  2015-06-03       Impact factor: 7.397

8.  Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses.

Authors:  Veronica Sanna; Antonio Di Giacomo; Antonio La Cava; Robert I Lechler; Silvia Fontana; Serafino Zappacosta; Giuseppe Matarese
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

9.  Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome.

Authors:  Christina L Ohland; Lisa Kish; Haley Bell; Aducio Thiesen; Naomi Hotte; Evelina Pankiv; Karen L Madsen
Journal:  Psychoneuroendocrinology       Date:  2013-04-06       Impact factor: 4.905

Review 10.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

View more
  25 in total

1.  A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.

Authors:  Sara L Colpitts; Eli J Kasper; Abigail Keever; Caleb Liljenberg; Trevor Kirby; Krisztian Magori; Lloyd H Kasper; Javier Ochoa-Repáraz
Journal:  Gut Microbes       Date:  2017-08-04

Review 2.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.

Authors:  Gilliard Lach; Harriet Schellekens; Timothy G Dinan; John F Cryan
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 3.  Brain-gut-microbiome interactions in obesity and food addiction.

Authors:  Arpana Gupta; Vadim Osadchiy; Emeran A Mayer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-27       Impact factor: 46.802

Review 4.  Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Authors:  Paolo Riccio; Rocco Rossano
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

5.  Microbiome as an Immunological Modifier.

Authors:  Manoj Kumar; Parul Singh; Selvasankar Murugesan; Marie Vetizou; John McCulloch; Jonathan H Badger; Giorgio Trinchieri; Souhaila Al Khodor
Journal:  Methods Mol Biol       Date:  2020

Review 6.  The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.

Authors:  Javier Ochoa-Repáraz; Lloyd H Kasper
Journal:  Transl Res       Date:  2016-07-28       Impact factor: 7.012

7.  The intestinal microbiota contributes to the growth and physiological state of muscle tissue in piglets.

Authors:  Renli Qi; Jing Sun; Xiaoyu Qiu; Yong Zhang; Jing Wang; Qi Wang; Jinxiu Huang; Liangpeng Ge; Zuohua Liu
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

Review 8.  Influence of gut microbiota on neuropsychiatric disorders.

Authors:  María Carmen Cenit; Yolanda Sanz; Pilar Codoñer-Franch
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

Review 9.  Metabolism Disrupting Chemicals and Alteration of Neuroendocrine Circuits Controlling Food Intake and Energy Metabolism.

Authors:  Marilena Marraudino; Brigitta Bonaldo; Alice Farinetti; GianCarlo Panzica; Giovanna Ponti; Stefano Gotti
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-09       Impact factor: 5.555

10.  Antidepressant effects of total iridoids of Valeriana jatamansi via the intestinal flora-blood-brain barrier pathway.

Authors:  Li Zhang; Liwen Wang; Li Huang; Yanni Zhao; Hongling Ding; Binglong Li; Lingmiao Wen; Wei Xiong; Yanjun Liu; Tinglan Zhang; Liudai Zhang; Lanlan Wu; Qing Xu; Yuqing Fan; Guihua Wei; Qiaozhi Yin; Yunhui Chen; Tiane Zhang; Zhiyong Yan
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.